|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||||||||
| Cash | |||||||||||||||
| Subscriptions receivable | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Total current assets | |||||||||||||||
| Other assets | |||||||||||||||
| NSR royalty asset | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Total assets | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued service expenses | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Commitments and contingencies | |||||||||||||||
| Stockholders’ Equity: | |||||||||||||||
| Preferred stock, value | |||||||||||||||
| Series A Preferred Stock | |||||||||||||||
| Series B Preferred Stock | |||||||||||||||
| Total preferred stock, value | |||||||||||||||
| Common Stock, $0.0001 par value; 100,000,000 shares authorized and 57,972,430 and 56,409,930 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||
Loading...
